NFE2
protein-codingnuclear factor, erythroid 2, the group of Basic leucine zipper proteins
Gene summary
Enables WW domain binding activity; identical protein binding activity; and sequence-specific double-stranded DNA binding activity. Contributes to cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including labyrinthine layer blood vessel development; negative regulation of bone mineralization; and positive regulation of peptidyl-lysine acetylation. Part of protein-DNA complex. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0002049
Submitter: ClinGen
*NFE2* was first reported in relation to inherited thrombocytopenia in 2020 (Luk et al, 2020 PMID: 31951293). *NFE2* is a DNA binding transcription factor involved in gene expression in erythroid and megakaryocytic cells. To date, there has been one report of a variant in *NFE2* causing severe thrombocytopenia with mild effects on erythroid cells. Additionally, somatic variants in *NFE2* have been well described in myeloproliferative neoplasms and are not included in this curation. Evidence supporting this gene-disease curation includes case level data and experimental data. Summary of Case Level Data (2 points): One homozygous frameshift variant causing gene truncation has been reported in a single proband (Luk et al, 2020 PMID: 31951293). Summary of Experimental Evidence (3.5 points): The gene-disease relationship is supported by expression studies (Andrews et al, 1993 PMID: 8469283), cell culture model system (Lecine et al, 1998 PMID: 9716588) and a mouse model system (Shivdasani el al, 1995 PMID: 7774011). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease relationship was curated by the ClinGen Hemostasis and Thrombosis (H/T) Gene Curation Expert Panel using Gene Clinical Validity Standard Operating Procedures (SOP), Version 11.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NFE2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001136023.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 40 | 1 | 41 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 40 | 2 | 0 | 42 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001129495.1 | 2 | MANE Select | |
| Ensembl | ENSP00000397185.2 | 2 | MANE Select | |
| RefSeq | NP_001248390.1 | 2 | Standard | |
| RefSeq | NP_001387294.1 | 2 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| nfe2 | Danio rerio | Structure: nucleate erythrocyte Quality: low saturation abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Hematopoietic Stem Cell Differentiation
- Steatosis AOP
- RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
- Gene expression (Transcription)
- Generic Transcription Pathway
Biological Process
- nucleosome disassembly
- regulation of transcription by RNA polymerase II
- multicellular organism development
- blood coagulation
- hemostasis
Molecular Function
- transcription regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- proximal promoter sequence-specific DNA binding
- DNA binding
- DNA-binding transcription factor activity
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- PML body
- protein-DNA complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000540264
- Coding exons
- 2
- Length
- 9011
- Individuals with no LoFs
- 125735
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 8
- Defined
- 125743
- p
- 0.0000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.22 | 176 | 228 | 0.772 | 0.0000146 | 2352 |
| Missense (PolyPhen) | 55 | 86.017 | 0.63941 | 809 | ||
| Synonymous | 0.327 | 91 | 95.1 | 0.957 | 0.00000529 | 831 |
| Loss of Function | 2.71 | 2 | 12.2 | 0.163 | 7.06e-7 | 142 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000030 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0.000049 | 0.000046 | rare |
| European (Non-Finnish) | 0.000010 | 0.0000088 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the NF-E2 complex essential for regulating erythroid and megakaryocytic maturation and differentiation. Binds to the hypersensitive site 2 (HS2) of the beta-globin control region (LCR). This subunit (NFE2) recognizes the TCAT/C sequence of the AP-1-like core palindrome present in a number of erythroid and megakaryocytic gene promoters. Requires MAFK or other small MAF proteins for binding to the NF-E2 motif. May play a role in all aspects of hemoglobin production from globin and heme synthesis to procurement of iron. {ECO:0000269|PubMed:11154691, ECO:0000269|PubMed:16287851}.;
Recessive Scores
- pRec
- 0.360
Intolerance Scores
- LoFtool
- 0.0570
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 33.97
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 1.00
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |